SCHEMBL8961415

SCHEMBL8961415

NC(N)CC(=O)O.[Cu]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL93579 0.97
Hydrochloric Acid SCHEMBL27534769 0.93
Hydrochloric Acid SCHEMBL8544926 0.93
Ethylene SCHEMBL8854307 0.90
SCHEMBL288510 0.76 SLC22A6 (0.50)
SCHEMBL2491274 0.76 SLC22A6 (0.50)
Aspartic Acid SCHEMBL28060155 0.75 GRIK1 (0.54)
Aspartic Acid SCHEMBL31453284 0.75 GRIK1 (0.54)
Aspartic Acid SCHEMBL27624117 0.75 GRIK1 (0.54)
SCHEMBL338756 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0693081-A1 CYCLIC COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION Novartis AG (CH) 1996-01-24 EP disclosed
WO-1994024153-A1 CYCLIC COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION CIBA-GEIGY AG (CH) 1994-10-27 WO disclosed